Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;22(7):943-945.
doi: 10.1016/S1473-3099(22)00362-0. Epub 2022 Jun 9.

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection

Affiliations

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection

Kim Blom et al. Lancet Infect Dis. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests. KB, UM, SHa, JK, and CT contributed equally. This research was funded by grants from the Knut and Alice Wallenberg Foundation (to CT and JK), the Jonas and Kristina af Jochnick Foundation (to CT), the Leif Lundblad Family Foundation (to CT), Region Stockholm (to CT), and Center for Innovative Medicine (to KB and JK).

Figures

Figure
Figure
Immune responses following omicron BTI in triple-vaccinated health-care workers with and without prior SARS-CoV-2 infection (A) GMTs (with 95% CIs) of anti-wildtype spike IgG at baseline and up to 5 weeks post-omicron BTI in participants without (n=20) and with (n=10) previous SARS-CoV-2 infection. The grey dots and dashed line represent participants who remained qPCR negative throughout the study period (n=69). (B) T-cell responses against SARS-CoV-2 S1 protein in participants without omicron BTI and 7 weeks post-infection in participants with omicron BTI; participants had no history of SARS-CoV-2 infection. Individual-participant data (dots) and GMTs (with 95% CIs; lines) are shown. (C) GMTs (with 95% CIs) of anti-spike IgG against wildtype, delta, and omicron BA.1 and BA.2 variants at baseline and 7 weeks after omicron BTI in participants without (n=40) and with (n=16) previous SARS-CoV-2 infection. (D) T-cell responses against SARS-CoV-2 S1 protein in participants without omicron BTI and 7 weeks post-infection in participants with omicron BTI; participants had a history of SARS-CoV-2 infection. Individual-participant data (dots) and GMTs (with 95% CIs; lines) are shown. BTI=breakthrough infection. GMT=geometric mean titre. ns=not significant. SFU=spot-forming units. *p<0·001. †p<0·01. ‡p<0·0001.

References

    1. Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet. 2022;399:234–236. - PMC - PubMed
    1. Pajon R, Doria-Rose NA, Shen X, et al. SARS-CoV-2 omicron variant neutralization after mRNA-1273 booster vaccination. N Engl J Med. 2022;386:1088–1091. - PMC - PubMed
    1. Rudberg A-S, Havervall S, Månberg A, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11 - PMC - PubMed
    1. Havervall S, Marking U, Greilert-Norin N, et al. Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time. Clin Transl Immunology. 2022;11 - PMC - PubMed
    1. Marking U, Havervall S, Norin NG, et al. High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated. medRxiv. 2022 doi: 10.1101/2022.04.02.22273333. published online April 3. - DOI

Publication types

Substances